Just Out $IMMB – Medical Science Play could become the Leade… – (IMMB) (CROWD)
admin | February 5, 2013 | 0 Comments
Immunotech Laboratories – IMMB Hello Subscribers, Our Newly featured ALERT: IMMB NEW ALERT: Immunotech Laboratories, Inc (IMMB) – .22 JUST RELEASED VIDEO with Bo Linton: http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...0CeGQWmgTg Begin your research here: http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...3o_4sO1rDA http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...14mT9ryaTw IMMB is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Immunotech is committed to creating drugs for the better health of mankind.
Immunotech`s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
How treatment works is: IMMB offers this innovative HIV / AIDS drug, Irreversible Pepsin Fraction (IPF) a platform technology that can be used to facilitate a broad range of applications.
It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. Read more… http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...A7X3egjgeg Treatments for HIV patients are low cost: less than 500 per treatment and only 3 treatments necessary. Thats remarkable! considering that the cost is less than most peoples medical insurance deductibles these days.
There are approx. 30 million people in Africa alone who suffer from HIV/AIDS.
According to Director Bo Linton in an interview with Undiscovered Companies, http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...0CeGQWmgTg potential revenues from HIV treatment when in full production is an astounding 750 per person worldwide. Multiply that by the number of HIV/AIDS patients across the world This does not even include cancer cures.
IMMB recently announced that it had been in negotiations with an International Bio-Tech Partner in the HIV cure technology sector for joint advanced Research & Development and the partner has agreed to provide the necessary funding for the USA Clinical Trials phases to ultimately achieve FDA approval for the medicines.
The terms include some exclusive rights for the International partner for use and distribution of the vaccines in several countries where the equivalent of FDA approval is not required and can be distributed and administered labeled as an “Experimental Drug”. This process will help accelerate the clinical trials results. Read more… http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...URzlFXR.wA Follow the CROWD and quickly put IMMB on your Watch List. With a float of only approx. 1 million shares, IMMB could be one of the most highly undervalued Medical Science plays on the small cap market. IMMB actually helps people. Their HIV treatment can save millions of lives as well as prevent prolonged suffering associated with HIV patients.
Sincerely, PennyStockCrowd.com
Just Out $IMMB – Medical Science Play could become the
Top 10 Most Recent News Articles
Infosys Award Recognizes Global Banking Innovation 2026
Championing Banking Innovations Globally If there's one thing you can count on in the financial world, it's innovation pushing the boundaries of how we bank. The 13th edition of the Qorus-Infosys Finacle Banking Innovation Awards has once again proven that innovation is not just a buzzword but a real, transformative force in the global banking landscape. This year, they...
Continue Reading
5W Lauded by Inc.'s Power Partner Awards in 2026
5W's Ascent in the PR World Who'd have thought a PR firm would bask in the limelight like this? 5W, a key player in the public relations jungle, is bagging recognition from Inc.'s Power Partner Awards this year. These awards aren't handed out like free samples; they're a shoutout to those who truly matter to businesses aiming for the stars. A Powerhouse of Visibility and...
Continue Reading
Coffee Bean Brews Up Nostalgia with Tiramisu Treats
Pouring Old Favorites: The Tiramisu Return When the aromas of coffee and nostalgia waft through the air, it's often a sign that The Coffee Bean & Tea Leaf® is brewing something special. This year, they've decided to double down on the holiday cheer by reintroducing their wildly popular Tiramisu beverage. This ain't just your run-of-the-mill coffee drink—it's a full-on...
Continue Reading
MUFG Debuts VAM for Streamlined Treasury Ops
MUFG's Bold Move into Digital Liquidity Alright, let's dive into MUFG's latest shake-up, and boy, it's no small fry. This Japanese financial giant's got its eyes set on transforming how businesses handle their cash with what they're calling Virtual Account Management, or VAM - a fancy name for a digital liquidity tool that's looking to cut the clutter of multiple bank...
Continue Reading
Marc Ryan Joins ABCS Insights as Chief Product Officer
Shaping the Future of Advertising Effectiveness In the ever-evolving ad measurement arena, where understanding what works can make or break a company, ABCS Insights has tossed a game-changing hat into the ring. They've just announced Marc Ryan as their new Chief Product Officer. Now, I’ve seen seasoned execs shuffle seats countless times, but this one’s...
Continue Reading
LG Energy Sparks Global Innovation with BIC 2026
Innovating Beyond Boundaries with LG Energy The world of battery tech is on fire, and LG Energy Solution is fanning the flames with their Battery Innovation Contest 2026 (BIC 2026). From October 29 to December 6, 2026, universities and research hives across the globe are being beckoned to pour their battery brilliance into this contest. These aren't just any research...
Continue Reading
HERVolution's HERV-K Antigens: A Cancer Breakthrough?
Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...
Continue Reading
Meritus Health Adopts Sectra's Cloud for Radiology Boost
Meritus' Bold Move into the Cloud Jumping headlong into the tech game, Meritus Health has teamed up with Sectra to harness their One Cloud solution. This isn't just a plug-and-play deal; it's a strategic bet to overhaul how radiology is done. Do you know the kind of back-and-forth it takes to get a diagnostic image these days? Too much, if you ask me. Meritus is going...
Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?
A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...
Continue Reading
EDB Enhances Postgres with Horizontal Scaling Preview
EDB's Ambitious Move Into Seamless Data Growth Right out of Wilmington, Delaware, EnterpriseDB (EDB) is sowing the seeds for a seismic change in how enterprises juggle their data systems. With 86% of the top brass anticipating AI data systems becoming top-tier indispensable, the unveiling of EDB’s horizontal scaling for their Postgres AI Distributed is a tune you just...
Continue ReadingTop 5 Most Recently Viewed Articles
Legal Action Looms for Agenus Inc. Investors Over Fraud Claims
Legal Action Looms for Investing in Agenus Inc. Agenus Inc. (NASDAQ: AGEN) has found itself at the center of a potential class action lawsuit, with its investors facing critical developments that could impact their financial standing. Investors who purchased shares during the defined class period are reminded of the essential deadlines to ensure their eligibility in...
Continue Reading
Colette Stevenson Discusses CCP and Its Impact on Real Estate
Insights from Colette Stevenson on the Clear Cooperation Policy In a recent discussion, Colette Stevenson, the CEO of REsides, shared her insights on the hot topic surrounding the Clear Cooperation Policy (CCP) that is causing much debate in the real estate industry. Recently, major platforms like Zillow and Redfin have made the significant move to ban private listings,...
Continue Reading
Saudi Arabia's COP16: Pioneering Initiatives for Land Restoration
Saudi Arabia's Bold Move at COP16 For the first time in history, the United Nations Convention to Combat Desertification (UNCCD) Conference of the Parties (COP) will feature a distinctive green zone and thematic days under Saudi Arabia's COP16 presidency. This innovative program is aimed at mobilizing global action to combat pressing issues like land degradation and...
Continue Reading
MetaEra Introduces the CryptoFi Forum Hong Kong Brand
MetaEra's Vision for the Future of Crypto Finance Strategically aimed at enhancing dialogue and collaboration in the crypto finance sector, MetaEra recently introduced the prestigious 'CryptoFi Forum Hong Kong'. This brand is set to facilitate discussions among diverse stakeholders, aiming to propel the industry forward. Forging Connections in a Growing Industry The...
Continue Reading
Urban Growers Collective Sets Path for Future Growth and Impact
Urban Growers Collective's 2021-2024 Impact Report Overview Community support sets the stage for UGC's bold 2026 growth Urban Growers Collective (UGC) is a Black–woman–led nonprofit dedicated to solutions for food accessibility and economic opportunity. The organization has released the 2021-2024 Impact Report, which highlights substantial initiatives aimed at...
Continue Reading